HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

6- methyl- 2- (4- (naphthylpiperazin- 1- yl)butyl)- 3- (2H)- pyridazinone

a partial agonist with antipsychotic and antiparkinsonian activities; structure in first source

Also Known As:

F 97013-GD; F-97013-GD

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Piperazines: 26
    - 6-methyl-2-(4-(naphthylpiperazin-1-yl)butyl)-3-(2H)-pyridazinone: 1
  - Pyridazines: 11
    - 6-methyl-2-(4-(naphthylpiperazin-1-yl)butyl)-3-(2H)-pyridazinone: 1

Experts

1.	Artaiz, Inés: 1 article (07/2006)
2.	Castro, Elena: 1 article (07/2006)
3.	Del Olmo, Elena: 1 article (07/2006)
4.	Innerárity, Ana: 1 article (07/2006)
5.	Labeaga, Luis: 1 article (07/2006)
6.	Orjales, Aurelio: 1 article (07/2006)
7.	Pazos, Angel: 1 article (07/2006)
8.	Zazpe, Arturo: 1 article (07/2006)

Related Diseases

1.	Catalepsy 07/01/2006 - "In addition, only high doses of F-97013-GD induced catalepsy in rodents and, like 8-OH-DPAT and clozapine, the compound reversed the haloperidol-induced catalepsy in rats. "

Related Drugs and Biologics

1.	8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)
2.	Haloperidol (Haldol)
3.	Clozapine (Clozaril)